Authors: Laske, C Oschmann, P Tofighi, J Kuhne, BS Diehl, H Bregenzer, T Kraus, J Chatzimanolis, N Bauer, R Traupe, H Kaps, M

Citation: C. Laske et al., Prognostic value of soluble tumor necrosis factor receptors 1 and 2 in multiple sclerosis patients treated with interferon beta-1b, EUR NEUROL, 46(4), 2001, pp. 210-214

Authors: Laske, C Oschmann, P Tofighi, J Kuehne, SB Diehl, H Bregenzer, T Kraus, J Bauer, R Chatzimanolis, N Kern, A Traupe, H Kaps, M

Citation: C. Laske et al., Induction of sTNF-R1 and sTNF-R2 by interferon beta-1b in correlation withclinical and MRI activity, ACT NEUR SC, 103(2), 2001, pp. 105-113

Authors: Kraus, J Oschmann, P Engelhardt, B Stolz, E Kuehne, BS Laske, C Schaefer, C Traupe, H Kaps, M

Citation: J. Kraus et al., CD45RA(+) ICAM-3(+) lymphocytes in cerebrospinal fluid and blood as markers of disease activity in patients with multiple sclerosis, ACT NEUR SC, 102(5), 2000, pp. 326-332

Authors: Kraus, J Oschmann, P Engelhardt, B Bauer, R Schiel, C Kern, A Stolz, E Traupe, A Dorndorf, W

Citation: J. Kraus et al., Soluble and cell surface ICAM-3 in blood and cerebrospinal fluid of patients with multiple sclerosis: influence of methylprednisolone treatment and relevance as markers for disease activity, ACT NEUR SC, 101(2), 2000, pp. 135-139

Authors: Kraiczy, P Peters, S Seitz, C Wurzner, R Oschmann, P Brade, V

Citation: P. Kraiczy et al., Growth inhibitory and bactericidal efficacy of sera from Lyme borreliosis patients on B-burgdorferi strains, WIEN KLIN W, 110(24), 1998, pp. 886-893